BioXcel Therapeutics (BTAIQ) Total Liabilities (Quarterly): 144.26M

BioXcel Therapeutics, Inc. (BTAIQ)

0.052 +0.01 (+15.56%) USD | OTCM | Oct 02, 16:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Start Trial.

Date	Value
June 30, 2026	144.26M
March 31, 2026	139.57M
December 31, 2025	142.98M
September 30, 2025	133.71M
June 30, 2025	133.46M
March 31, 2025	128.74M
December 31, 2024	131.44M
September 30, 2024	134.52M
June 30, 2024	139.74M
March 31, 2024	154.69M
December 31, 2023	130.21M
September 30, 2023	141.06M
June 30, 2023	134.23M
March 31, 2023	127.10M
December 31, 2022	129.08M
September 30, 2022	117.83M
June 30, 2022	83.97M
March 31, 2022	17.02M
December 31, 2021	17.77M
September 30, 2021	15.78M

Date	Value
June 30, 2021	13.70M
March 31, 2021	13.65M
December 31, 2020	13.24M
September 30, 2020	17.81M
June 30, 2020	17.07M
March 31, 2020	13.23M
December 31, 2019	9.497M
September 30, 2019	9.277M
June 30, 2019	9.121M
March 31, 2019	7.96M
December 31, 2018	4.66M
September 30, 2018	2.043M
June 30, 2018	1.389M
March 31, 2018	4.215M
December 31, 2017	2.337M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016	0.331M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks